![]()
Gene-Chemical Interaction Annotations Click to see Annotation Detail View
Object Symbol | Species | Term | Qualifier | Evidence | With | Reference | Notes | Source | Original Reference(s) | Prr5l | Rat | 1,1-dichloroethene | increases expression | ISO | Prr5l (Mus musculus) | 6480464 | vinylidene chloride results in increased expression of PRR5L mRNA | CTD | PMID:26682919 | Prr5l | Rat | 1,2-dichloroethane | increases expression | ISO | Prr5l (Mus musculus) | 6480464 | ethylene dichloride results in increased expression of PRR5L mRNA | CTD | PMID:28960355 | Prr5l | Rat | 17beta-estradiol | increases expression | ISO | PRR5L (Homo sapiens) | 6480464 | Estradiol results in increased expression of PRR5L mRNA | CTD | PMID:23019147 | Prr5l | Rat | 17beta-estradiol | decreases expression | ISO | Prr5l (Mus musculus) | 6480464 | Estradiol results in decreased expression of PRR5L mRNA | CTD | PMID:39298647 | Prr5l | Rat | 17beta-estradiol | multiple interactions | ISO | PRR5L (Homo sapiens) | 6480464 | [Estradiol co-treated with TGFB1 protein] results in increased expression of PRR5L mRNA | CTD | PMID:30165855 | Prr5l | Rat | 3,4-methylenedioxymethamphetamine | increases expression | ISO | Prr5l (Mus musculus) | 6480464 | N-Methyl-3 and 4-methylenedioxyamphetamine results in increased expression of PRR5L mRNA | CTD | PMID:20188158 | Prr5l | Rat | 4,4'-sulfonyldiphenol | decreases expression | ISO | Prr5l (Mus musculus) | 6480464 | bisphenol S results in decreased expression of PRR5L mRNA | CTD | PMID:39298647 | Prr5l | Rat | 4-hydroxyphenyl retinamide | increases expression | ISO | Prr5l (Mus musculus) | 6480464 | Fenretinide results in increased expression of PRR5L mRNA | CTD | PMID:28973697 | Prr5l | Rat | 5-aza-2'-deoxycytidine | affects expression | ISO | PRR5L (Homo sapiens) | 6480464 | Decitabine affects the expression of PRR5L mRNA | CTD | PMID:23300844 | Prr5l | Rat | 6-propyl-2-thiouracil | decreases expression | EXP | | 6480464 | Propylthiouracil results in decreased expression of PRR5L mRNA | CTD | PMID:24780913 and PMID:25825206 | Prr5l | Rat | acrolein | multiple interactions | ISO | PRR5L (Homo sapiens) | 6480464 | [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased expression of and results in increased oxidation of PRR5L mRNA and [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in increased expression of and results in increased oxidation of PRR5L mRNA | CTD | PMID:32699268 | Prr5l | Rat | aflatoxin B1 | decreases methylation | ISO | PRR5L (Homo sapiens) | 6480464 | Aflatoxin B1 results in decreased methylation of PRR5L gene | CTD | PMID:27153756 | Prr5l | Rat | alpha-pinene | multiple interactions | ISO | PRR5L (Homo sapiens) | 6480464 | [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased expression of and results in increased oxidation of PRR5L mRNA and [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in increased expression of and results in increased oxidation of PRR5L mRNA | CTD | PMID:32699268 | Prr5l | Rat | arsane | multiple interactions | ISO | PRR5L (Homo sapiens) | 6480464 | [sodium arsenate results in increased abundance of Arsenic] which results in increased expression of PRR5L mRNA | CTD | PMID:32525701 | Prr5l | Rat | arsane | affects methylation | ISO | PRR5L (Homo sapiens) | 6480464 | Arsenic affects the methylation of PRR5L gene | CTD | PMID:25304211 | Prr5l | Rat | arsenic atom | affects methylation | ISO | PRR5L (Homo sapiens) | 6480464 | Arsenic affects the methylation of PRR5L gene | CTD | PMID:25304211 | Prr5l | Rat | arsenic atom | multiple interactions | ISO | PRR5L (Homo sapiens) | 6480464 | [sodium arsenate results in increased abundance of Arsenic] which results in increased expression of PRR5L mRNA | CTD | PMID:32525701 | Prr5l | Rat | benzo[a]pyrene | decreases expression | ISO | Prr5l (Mus musculus) | 6480464 | Benzo(a)pyrene results in decreased expression of PRR5L mRNA | CTD | PMID:21569818 | Prr5l | Rat | benzo[a]pyrene | increases expression | ISO | PRR5L (Homo sapiens) | 6480464 | Benzo(a)pyrene results in increased expression of PRR5L mRNA | CTD | PMID:32234424 | Prr5l | Rat | benzo[a]pyrene | increases methylation | ISO | PRR5L (Homo sapiens) | 6480464 | Benzo(a)pyrene results in increased methylation of PRR5L promoter | CTD | PMID:27901495 | Prr5l | Rat | benzo[a]pyrene | decreases methylation | ISO | PRR5L (Homo sapiens) | 6480464 | Benzo(a)pyrene results in decreased methylation of PRR5L 3' UTR | CTD | PMID:27901495 | Prr5l | Rat | benzo[a]pyrene | affects methylation | ISO | PRR5L (Homo sapiens) | 6480464 | Benzo(a)pyrene affects the methylation of PRR5L 5' UTR | CTD | PMID:27901495 | Prr5l | Rat | benzo[e]pyrene | decreases methylation | ISO | PRR5L (Homo sapiens) | 6480464 | benzo(e)pyrene results in decreased methylation of PRR5L intron | CTD | PMID:30157460 | Prr5l | Rat | bis(2-chloroethyl) sulfide | affects expression | EXP | | 6480464 | Mustard Gas affects the expression of PRR5L mRNA | CTD | PMID:15651846 | Prr5l | Rat | bisphenol A | affects expression | EXP | | 6480464 | bisphenol A affects the expression of PRR5L mRNA | CTD | PMID:25181051 | Prr5l | Rat | bisphenol A | decreases methylation | ISO | PRR5L (Homo sapiens) | 6480464 | bisphenol A results in decreased methylation of PRR5L gene | CTD | PMID:31601247 | Prr5l | Rat | bisphenol A | increases expression | ISO | Prr5l (Mus musculus) | 6480464 | bisphenol A results in increased expression of PRR5L mRNA | CTD | PMID:32156529 and PMID:34585602 | Prr5l | Rat | butan-1-ol | multiple interactions | ISO | PRR5L (Homo sapiens) | 6480464 | [[Gasoline co-treated with 1-Butanol] results in increased abundance of [Particulate Matter co-treated with Polycyclic Aromatic Hydrocarbons]] which results in decreased expression of PRR5L mRNA | CTD | PMID:29432896 | Prr5l | Rat | butanal | decreases expression | ISO | PRR5L (Homo sapiens) | 6480464 | butyraldehyde results in decreased expression of PRR5L mRNA | CTD | PMID:26079696 | Prr5l | Rat | calcitriol | increases expression | ISO | PRR5L (Homo sapiens) | 6480464 | Calcitriol results in increased expression of PRR5L mRNA | CTD | PMID:16002434 | Prr5l | Rat | cannabidiol | decreases expression | ISO | PRR5L (Homo sapiens) | 6480464 | Cannabidiol results in decreased expression of PRR5L mRNA | CTD | PMID:33244087 | Prr5l | Rat | carbon nanotube | decreases expression | ISO | Prr5l (Mus musculus) | 6480464 | Nanotubes and Carbon results in decreased expression of PRR5L mRNA | CTD | PMID:25554681 | Prr5l | Rat | chloroprene | decreases expression | ISO | Prr5l (Mus musculus) | 6480464 | Chloroprene results in decreased expression of PRR5L mRNA | CTD | PMID:23125180 | Prr5l | Rat | chlorpyrifos | increases expression | ISO | Prr5l (Mus musculus) | 6480464 | Chlorpyrifos results in increased expression of PRR5L mRNA | CTD | PMID:37019170 | Prr5l | Rat | chromium(6+) | affects expression | ISO | Prr5l (Mus musculus) | 6480464 | chromium hexavalent ion affects the expression of PRR5L mRNA | CTD | PMID:28472532 | Prr5l | Rat | cisplatin | affects expression | ISO | PRR5L (Homo sapiens) | 6480464 | Cisplatin affects the expression of PRR5L mRNA | CTD | PMID:23300844 | Prr5l | Rat | clothianidin | increases expression | ISO | PRR5L (Homo sapiens) | 6480464 | clothianidin results in increased expression of PRR5L mRNA | CTD | PMID:31626844 | Prr5l | Rat | coumarin | decreases phosphorylation | ISO | PRR5L (Homo sapiens) | 6480464 | coumarin results in decreased phosphorylation of PRR5L protein | CTD | PMID:35688186 | Prr5l | Rat | Cuprizon | decreases expression | EXP | | 6480464 | Cuprizone results in decreased expression of PRR5L mRNA | CTD | PMID:26577399 and PMID:27523638 | Prr5l | Rat | DDE | increases expression | ISO | PRR5L (Homo sapiens) | 6480464 | Dichlorodiphenyl Dichloroethylene results in increased expression of PRR5L mRNA | CTD | PMID:38568856 | Prr5l | Rat | deoxynivalenol | decreases expression | ISO | PRR5L (Homo sapiens) | 6480464 | deoxynivalenol results in decreased expression of PRR5L mRNA | CTD | PMID:26763390 | Prr5l | Rat | Dibutyl phosphate | affects expression | ISO | PRR5L (Homo sapiens) | 6480464 | di-n-butylphosphoric acid affects the expression of PRR5L mRNA | CTD | PMID:37042841 | Prr5l | Rat | diethylstilbestrol | increases expression | ISO | PRR5L (Homo sapiens) | 6480464 | Diethylstilbestrol results in increased expression of PRR5L mRNA | CTD | PMID:19371625 | Prr5l | Rat | dimethylarsinic acid | multiple interactions | ISO | Prr5l (Mus musculus) | 6480464 | [sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of PRR5L mRNA | CTD | PMID:34876320 | Prr5l | Rat | dioxygen | multiple interactions | ISO | Prr5l (Mus musculus) | 6480464 | [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of PRR5L mRNA | CTD | PMID:30529165 | Prr5l | Rat | dioxygen | multiple interactions | EXP | | 6480464 | [Oxygen deficiency co-treated with Blood Glucose deficiency co-treated with Particulate Matter] results in increased expression of PRR5L mRNA | CTD | PMID:33729688 | Prr5l | Rat | diuron | decreases expression | EXP | | 6480464 | Diuron results in decreased expression of PRR5L mRNA | CTD | PMID:21551480 | Prr5l | Rat | dorsomorphin | multiple interactions | ISO | PRR5L (Homo sapiens) | 6480464 | [NOG protein co-treated with Vorinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of PRR5L mRNA | CTD | PMID:27188386 | Prr5l | Rat | endosulfan | increases expression | EXP | | 6480464 | Endosulfan results in increased expression of PRR5L mRNA | CTD | PMID:29391264 | Prr5l | Rat | folic acid | increases expression | ISO | Prr5l (Mus musculus) | 6480464 | Folic Acid results in increased expression of PRR5L mRNA | CTD | PMID:25629700 | Prr5l | Rat | genistein | decreases expression | ISO | Prr5l (Mus musculus) | 6480464 | Genistein results in decreased expression of PRR5L mRNA | CTD | PMID:27539829 and PMID:32186404 | Prr5l | Rat | lipopolysaccharide | decreases expression | ISO | PRR5L (Homo sapiens) | 6480464 | Lipopolysaccharides results in decreased expression of PRR5L mRNA | CTD | PMID:35811015 | Prr5l | Rat | lipopolysaccharide | multiple interactions | ISO | PRR5L (Homo sapiens) | 6480464 | [S-(1 more ... | CTD | PMID:35811015 | Prr5l | Rat | methamphetamine | increases expression | EXP | | 6480464 | Methamphetamine results in increased expression of PRR5L mRNA | CTD | PMID:19564919 | Prr5l | Rat | methapyrilene | decreases methylation | ISO | PRR5L (Homo sapiens) | 6480464 | Methapyrilene results in decreased methylation of PRR5L intron | CTD | PMID:30157460 | Prr5l | Rat | methotrexate | decreases expression | ISO | PRR5L (Homo sapiens) | 6480464 | Methotrexate results in decreased expression of PRR5L mRNA | CTD | PMID:24449571 | Prr5l | Rat | methoxychlor | affects methylation | EXP | | 6480464 | Methoxychlor affects the methylation of PRR5L gene | CTD | PMID:35440735 | Prr5l | Rat | methylarsonic acid | multiple interactions | ISO | Prr5l (Mus musculus) | 6480464 | [sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of PRR5L mRNA | CTD | PMID:34876320 | Prr5l | Rat | N-Nitrosopyrrolidine | increases expression | ISO | PRR5L (Homo sapiens) | 6480464 | N-Nitrosopyrrolidine results in increased expression of PRR5L mRNA | CTD | PMID:32234424 | Prr5l | Rat | nickel atom | decreases expression | ISO | PRR5L (Homo sapiens) | 6480464 | Nickel results in decreased expression of PRR5L mRNA | CTD | PMID:23195993 | Prr5l | Rat | O-methyleugenol | increases expression | ISO | PRR5L (Homo sapiens) | 6480464 | methyleugenol results in increased expression of PRR5L mRNA | CTD | PMID:32234424 | Prr5l | Rat | oxaliplatin | multiple interactions | EXP | | 6480464 | [oxaliplatin co-treated with Topotecan] results in increased expression of PRR5L mRNA | CTD | PMID:25729387 | Prr5l | Rat | oxaliplatin | increases expression | EXP | | 6480464 | oxaliplatin results in increased expression of PRR5L mRNA | CTD | PMID:25729387 | Prr5l | Rat | ozone | multiple interactions | ISO | PRR5L (Homo sapiens) | 6480464 | [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased expression of and results in increased oxidation of PRR5L mRNA more ... | CTD | PMID:32699268 | Prr5l | Rat | ozone | multiple interactions | ISO | Prr5l (Mus musculus) | 6480464 | [Air Pollutants results in increased abundance of [Ozone co-treated with Soot]] which results in decreased expression of PRR5L mRNA | CTD | PMID:34911549 | Prr5l | Rat | paracetamol | increases expression | ISO | PRR5L (Homo sapiens) | 6480464 | Acetaminophen results in increased expression of PRR5L mRNA | CTD | PMID:26690555 | Prr5l | Rat | paracetamol | decreases expression | EXP | | 6480464 | Acetaminophen results in decreased expression of PRR5L mRNA | CTD | PMID:33387578 | Prr5l | Rat | paraquat | decreases expression | EXP | | 6480464 | Paraquat results in decreased expression of PRR5L mRNA | CTD | PMID:32680482 | Prr5l | Rat | Rutecarpine | decreases expression | ISO | PRR5L (Homo sapiens) | 6480464 | rutecarpine results in decreased expression of PRR5L mRNA | CTD | PMID:34955744 | Prr5l | Rat | S-(1,2-dichlorovinyl)-L-cysteine | multiple interactions | ISO | PRR5L (Homo sapiens) | 6480464 | [S-(1 more ... | CTD | PMID:35811015 | Prr5l | Rat | SB 431542 | multiple interactions | ISO | PRR5L (Homo sapiens) | 6480464 | [NOG protein co-treated with Vorinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of PRR5L mRNA | CTD | PMID:27188386 | Prr5l | Rat | silicon dioxide | decreases expression | ISO | PRR5L (Homo sapiens) | 6480464 | Silicon Dioxide analog results in decreased expression of PRR5L mRNA | CTD | PMID:25895662 | Prr5l | Rat | sodium arsenate | multiple interactions | ISO | PRR5L (Homo sapiens) | 6480464 | [sodium arsenate results in increased abundance of Arsenic] which results in increased expression of PRR5L mRNA | CTD | PMID:32525701 | Prr5l | Rat | sodium arsenate | multiple interactions | ISO | Prr5l (Mus musculus) | 6480464 | [sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of PRR5L mRNA | CTD | PMID:34876320 | Prr5l | Rat | sodium arsenate | increases expression | ISO | Prr5l (Mus musculus) | 6480464 | sodium arsenate results in increased expression of PRR5L mRNA | CTD | PMID:30953684 | Prr5l | Rat | sodium arsenite | affects expression | ISO | PRR5L (Homo sapiens) | 6480464 | sodium arsenite affects the expression of PRR5L mRNA | CTD | PMID:29301061 | Prr5l | Rat | sodium arsenite | multiple interactions | ISO | Prr5l (Mus musculus) | 6480464 | [sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of PRR5L mRNA | CTD | PMID:34876320 | Prr5l | Rat | sodium arsenite | decreases expression | ISO | Prr5l (Mus musculus) | 6480464 | sodium arsenite results in decreased expression of PRR5L mRNA | CTD | PMID:37682722 | Prr5l | Rat | sotorasib | multiple interactions | ISO | PRR5L (Homo sapiens) | 6480464 | [sotorasib co-treated with trametinib co-treated with NVP-BKM120] results in decreased expression of PRR5L mRNA | CTD | PMID:36139627 | Prr5l | Rat | sulforaphane | decreases expression | ISO | PRR5L (Homo sapiens) | 6480464 | sulforaphane results in decreased expression of PRR5L mRNA | CTD | PMID:31838189 | Prr5l | Rat | temozolomide | increases expression | ISO | PRR5L (Homo sapiens) | 6480464 | Temozolomide results in increased expression of PRR5L mRNA | CTD | PMID:31758290 | Prr5l | Rat | tetraphene | increases expression | ISO | Prr5l (Mus musculus) | 6480464 | benz(a)anthracene results in increased expression of PRR5L mRNA | CTD | PMID:26377693 | Prr5l | Rat | thimerosal | decreases expression | ISO | PRR5L (Homo sapiens) | 6480464 | Thimerosal results in decreased expression of PRR5L mRNA | CTD | PMID:27188386 | Prr5l | Rat | thioacetamide | increases expression | EXP | | 6480464 | Thioacetamide results in increased expression of PRR5L mRNA | CTD | PMID:34492290 | Prr5l | Rat | titanium dioxide | decreases expression | ISO | Prr5l (Mus musculus) | 6480464 | titanium dioxide results in decreased expression of PRR5L mRNA | CTD | PMID:27760801 | Prr5l | Rat | titanium dioxide | decreases methylation | ISO | Prr5l (Mus musculus) | 6480464 | titanium dioxide results in decreased methylation of PRR5L gene | CTD | PMID:35295148 | Prr5l | Rat | topotecan | multiple interactions | EXP | | 6480464 | [oxaliplatin co-treated with Topotecan] results in increased expression of PRR5L mRNA | CTD | PMID:25729387 | Prr5l | Rat | topotecan | increases expression | EXP | | 6480464 | Topotecan results in increased expression of PRR5L mRNA | CTD | PMID:25729387 | Prr5l | Rat | trametinib | multiple interactions | ISO | PRR5L (Homo sapiens) | 6480464 | [sotorasib co-treated with trametinib co-treated with NVP-BKM120] results in decreased expression of PRR5L mRNA | CTD | PMID:36139627 | Prr5l | Rat | trichostatin A | decreases expression | ISO | PRR5L (Homo sapiens) | 6480464 | trichostatin A results in decreased expression of PRR5L mRNA | CTD | PMID:24935251 | Prr5l | Rat | triphenyl phosphate | affects expression | ISO | PRR5L (Homo sapiens) | 6480464 | triphenyl phosphate affects the expression of PRR5L mRNA | CTD | PMID:37042841 | Prr5l | Rat | triptonide | increases expression | ISO | Prr5l (Mus musculus) | 6480464 | triptonide results in increased expression of PRR5L mRNA | CTD | PMID:33045310 | Prr5l | Rat | valproic acid | affects expression | ISO | Prr5l (Mus musculus) | 6480464 | Valproic Acid affects the expression of PRR5L mRNA | CTD | PMID:17292431 | Prr5l | Rat | valproic acid | affects expression | ISO | PRR5L (Homo sapiens) | 6480464 | Valproic Acid affects the expression of PRR5L mRNA | CTD | PMID:25979313 | Prr5l | Rat | valproic acid | decreases expression | ISO | PRR5L (Homo sapiens) | 6480464 | Valproic Acid results in decreased expression of PRR5L mRNA | CTD | PMID:24383497 and PMID:28001369 | Prr5l | Rat | vorinostat | multiple interactions | ISO | PRR5L (Homo sapiens) | 6480464 | [NOG protein co-treated with Vorinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of PRR5L mRNA | CTD | PMID:27188386 | Prr5l | Rat | vorinostat | decreases expression | ISO | PRR5L (Homo sapiens) | 6480464 | vorinostat results in decreased expression of PRR5L mRNA | CTD | PMID:26272509 | Prr5l | Rat | zinc atom | decreases expression | ISO | PRR5L (Homo sapiens) | 6480464 | Zinc deficiency results in decreased expression of PRR5L mRNA | CTD | PMID:22171008 | Prr5l | Rat | zinc(0) | decreases expression | ISO | PRR5L (Homo sapiens) | 6480464 | Zinc deficiency results in decreased expression of PRR5L mRNA | CTD | PMID:22171008 | |